NCT01506050View on ClinicalTrials.gov

Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

February 28, 2006

Conditions
Healthy
Interventions
DRUG

Desloratadine

Desloratadine ODT 5 mg

Trial Locations (1)

33901

SFBC Ft Myers Inc, Broadway

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY